334 filings
Page 5 of 17
425
7l0pu5s7e3 m2sx3a
27 Oct 05
Business combination disclosure
12:00am
425
j3yvzkjmux1zlj
18 Oct 05
Business combination disclosure
12:00am
DEFA14A
kodz5co5 h8zxxuw
18 Oct 05
Additional proxy soliciting materials
12:00am
425
vu8iwo41m7ibhjlm04x
17 Oct 05
Business combination disclosure
12:00am
425
rmg6ya
17 Oct 05
Business combination disclosure
12:00am
425
yjr1nyc4q304nf5vkeu9
17 Oct 05
Business combination disclosure
12:00am
425
9wur2uusnef 9iyx
13 Oct 05
Business combination disclosure
12:00am
DEFA14A
g5f5d alrol
13 Oct 05
Additional proxy soliciting materials
12:00am
425
s03m0ky28es vb9c
12 Oct 05
Business combination disclosure
12:00am
8-K
q32 3se2e
12 Oct 05
Teva and IVAX Receive FTC Request for Additional Information
12:00am
425
ye5f63zdcn2n60wqho
12 Oct 05
Business combination disclosure
12:00am
425
gq2cay8u7ih2h g1w
4 Oct 05
Business combination disclosure
12:00am
DEFA14A
j2u 85kgfa
4 Oct 05
Additional proxy soliciting materials
12:00am
8-K
ead8x6dihy34pqy jt
3 Oct 05
IVAX Announces Conversion Period for 1.875% Convertible Notes
12:00am
425
pargd9le u9kljp
23 Sep 05
Business combination disclosure
12:00am
8-K
sup9f3z62 62m
21 Sep 05
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
7hn5h4 trzdlqfu
21 Sep 05
Entry into a Material Definitive Agreement
12:00am
425
zvtnbabxyc6qc
21 Sep 05
Business combination disclosure
12:00am
425
nq3aii5
20 Sep 05
Business combination disclosure
12:00am
424B3
ni80c8 chjbm51f6q
15 Aug 05
Prospectus supplement
12:00am